Information Provided By:
Fly News Breaks for September 26, 2019
TECH
Sep 26, 2019 | 09:03 EDT
SVB Leerink analyst Puneet Souda raised his price target for Bio-Techne to $240 from $230 given higher conviction in both near- and long-term estimates. The analyst recently met with management and came away with a view that the company is likely to deliver a "strong" Q1 quarter, while its long-term 2023 estimates also remain conservative in light of key organic growth drivers. He reiterates an Outperform rating on the shares.